Eubacterium rectale
Eubacterium rectale is a gram-positive, obligate anaerobe and prominent butyrate-producing member of the human gut microbiota, where it is typically one of the more abundant bacterial species. It is not a recognized commercial probiotic and is not used in supplements; research on this organism focuses on its ecological role in the gut ecosystem rather than therapeutic applications. Its capacity to ferment resistant starches and produce butyrate, a short-chain fatty acid used as fuel by colonic cells, has been documented in laboratory and animal-model settings. E. rectale abundance has been studied in relation to gut health indicators and has been examined across several gastrointestinal conditions, using observational and correlational study designs. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 328 body-system-tagged papers that concern each system. Research coverage, not measured effect.
+4 more systems
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 112 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+13 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
664 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →The influence of selected antioxidants on the growth and metabolism of Eubacterium rectale· Repository of the University of Ljubljana (University of Ljubljana) · 2026
-
[2]
PMID 35869734 →Effects of Clostridium butyricum Capsules Combined with Rosuvastatin on IntestinalFlora, Lipid Metabolism, Liver Function and Inflammation in NAFLD Patients· Cellular and Molecular Biology · 2022
-
[3]
PMID 25388295 →Molecular details of a starch utilization pathway in the human gut symbiont Eubacterium rectale· Molecular Microbiology · 2014
-
[4]
PMID 23038174 →Gut microbiome composition is linked to whole grain-induced immunological improvements· The ISME Journal · 2012
-
[5]
PMID 19222573 →Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine· FEMS Microbiology Letters · 2009
-
[6]
PMID 19321416 →Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla· Proceedings of the National Academy of Sciences · 2009